Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...

Fintel reports that on October 31, 2025, Benchmark maintained coverage of Belite Bio, Inc - Depositary Receipt (NasdaqCM:BLTE) with a Buy recommendation. Analyst Price Forecast Suggests 10.32% ...

OpenAI has announced a $15 million seed investment in Red Queen Bio, a startup focused on using AI to block the creation of ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from ...

G3 and Pivot Bio CERT-N(TM) add application flexibility and micronutrient delivery for 2026, expanding early-season access to reliable, weatherproof nitrogen. MINNEAPOLIS, Nov. 13, 2025 /PRNewswire/ - ...

A Seattle biotech startup born from a Nobel laureate's lab has landed $12.7 million and partnerships with pharmaceutical ...

Pure Bio Labs sued Teloyouth on Aug. 5 in Texas Western District Court over the use of the abbreviation "BPC" in the marketing of dietary supplements. The suit, brought by Kearney, McWilliams & Davis, ...

A new analysis of the SELECT trial – the largest and longest clinical trial to date examining the cardiovascular benefits of semaglutide (a medication used to support weight loss and diabetes ...

J.P. Morgan, Jefferies, Citigroup and TD Cowen are acting as joint book-running managers for the proposed offering.

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen ...

Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 ...